menu search

Libtayo® (cemiplimab) neoadjuvant treatment demonstrates encouraging event-free survival in patients with resectable cutaneous squamous cell carcinoma (cscc)

89% estimated event-free survival at one year among patients with stage II to IV resectable CSCC who received Libtayo prior to surgery in a Phase 2 tr...

October 21, 2023, 12:48 pm

Dmk pharmaceuticals announces inducement option grant under nasdaq listing rule 5635(c)(4)

SAN DIEGO, Oct. 20, 2023 (GLOBE NEWSWIRE) — DMK pharmaceuticals Corporation (NASDAQ: DMK), a commerci...

October 20, 2023, 8:15 pm

Ligand pharmaceuticals (lgnd) sees a more significant dip than broader market: some facts to know

In the closing of the recent trading day, Ligand pharmaceuticals (LGND) stood at $52.09, denoting a -1....

October 20, 2023, 7:33 pm

Ani pharmaceuticals (anip) increases despite market slip: here's what you need to know

ANI pharmaceuticals (ANIP) closed at $57.44 in the latest trading session, marking a +0.23% move from t...

October 20, 2023, 7:33 pm

: lipella pharmaceuticals stock more than doubles in 3 days as fda approves ind for olp treatment

Shares of Lipella pharmaceuticals Inc. LIPO rocketed 52.2% higher in very active tracing Friday, after ...

October 20, 2023, 2:47 pm

Adial pharmaceuticals announces $4 million private placement priced at-the-market under nasdaq rules

CHARLOTTESVILLE, Va., Oct. 20, 2023 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) (“Adial” or the “Company”), a clinical-stag...

October 20, 2023, 12:00 pm

Biocryst to host r&d day on november 3

RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2023 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will h...

October 20, 2023, 11:00 am

Lipella pharmaceuticals stock more than doubles in 3 days as fda approves ind for olp treatment

Shares of Lipella pharmaceuticals Inc. LIPO, +51.55% rocketed 52.2% higher in very active tracing Frida...

October 20, 2023, 10:47 am

Terns pharmaceuticals to participate in upcoming investor conferences

FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...

October 19, 2023, 8:05 pm

Shareholder alert: pomerantz law firm investigates claims on behalf of investors of alnylam pharmaceuticals, inc. – alny

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc. (“Alnylam...

October 19, 2023, 7:33 pm

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of alnylam pharmaceuticals, inc.(alny)

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam Pharmaceuticals, In...

October 19, 2023, 5:13 pm

Gild or vrtx: which is the better value stock right now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Gilead Sciences (GILD) and Vertex ...

October 19, 2023, 12:47 pm

Adial pharmaceuticals to present at the fall foliage microcap rodeo conference on october 25th

CHARLOTTESVILLE, VA / ACCESSWIRE / October 19, 2023 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharma...

October 19, 2023, 12:00 pm

Is invesco pharmaceuticals etf (pjp) a strong etf right now?

A smart beta exchange traded fund, the Invesco pharmaceuticals ETF (PJP) debuted on 06/23/2005, and off...

October 19, 2023, 7:31 am

3 solid stocks to buy for superb earnings acceleration

Invest in stocks such as Catalyst pharmaceuticals (CPRX), ImmunoGen (IMGN) and Inari Medical (NARI) for...

October 18, 2023, 7:31 am

J&j's medical device sales feel the side effects of weight-loss drugs

Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%.  The ...

October 17, 2023, 11:05 pm

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of alnylam pharmaceuticals, inc.

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam Pharmaceuticals, In...

October 17, 2023, 10:06 pm

Oric pharmaceuticals to present initial phase 1b clinical data for oric 114 in egfr/her2 exon 20 mutated nsclc at the european society of medical oncology (esmo) congress 2023

Company to host a conference call and webcast on Saturday, October 21, 2023, at 9:00 am ET featuring Dr. Alexander Spira to discuss initial data and p...

October 17, 2023, 4:30 pm

Neurobo to present at the h.c. wainwright 7th annual nash investor conference

BOSTON , Oct. 17, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform ca...

October 17, 2023, 8:01 am

Jay glazer teams up with supernus pharmaceuticals to raise awareness of adhd and his qelbree® journey

Jay is sharing his story of receiving an ADHD diagnosis and eventually finding his treatment approach with Qelbree 15.7 million U.S. children, teens a...

October 16, 2023, 9:34 pm


Search within

Pages Search Results: